Respiratory Syncytial Virus antibody

This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.

Application Name	Verified	Min Dilution	Max Dilution
ELISA
Functional Assays 1
Immunofluorescence
Immunohistology - Frozen

1. ¹This product contains sodium azide, removal by dialysis is recommended prior to use in functional assays.

Description	Product Code	Applications	Pack Size	List Price	Your Price	Quantity
Rabbit anti Goat IgG (Fc):FITC	STAR122F	F	1 mg		Log in	- +	Add to Cart Add to Quote Get Quote
List Price	Your Price
	Log in
Description	Rabbit anti Goat IgG (Fc):FITC
Rabbit anti Goat IgG (Fc):HRP	STAR122P	C E WB	1 mg		Log in	- +	Add to Cart Add to Quote Get Quote
List Price	Your Price
	Log in
Description	Rabbit anti Goat IgG (Fc):HRP

References for Respiratory Syncytial Virus antibody

1. Culley, F.J. et al. (2006) Role of CCL5 (RANTES) in viral lung disease.
   J Virol. 80: 8151-7.
2. Numata, M. et al. (2010) Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.
   Proc Natl Acad Sci U S A. 107: 320-5.
3. Roux, X. et al. (2008) Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.
   PLoS One. 3: e1766.
4. Olszewska, W. et al. (2011) Antiviral and lung protective activity of a novel RSV fusion inhibitor in a mouse model.
   Eur Respir J. 38: 401-8.
5. Fonceca AM et al. (2012) Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection.
   Thorax. 67 (1): 42-8.
6. Ryzhakov, G. et al. (2011) IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells.
   J Immunol. 187: 5357-62.
7. Fricke J et al. (2013) p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly.
   J Virol. 87 (3): 1333-47.
8. Kipper, S. et al. (2015) New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein.
   Mol Cell Proteomics. 14 (3): 532-43.
View The Latest Product References
9. Russell, R.F. et al. (2015) Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.
   J Virol. 89 (17): 8974-81.
10. Currie, S.M. et al. (2016) Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
    J Immunol. 196 (6): 2699-710.
11. Kinnear, E. et al. (2017) Airway T cells protect against RSV infection in the absence of antibody.
    Mucosal Immunol. May 24. [Epub ahead of print]
12. Bajimaya, S. et al. (2017) Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.
    Virology. 510: 234-41.
13. Choi, E.J. et al. (2018) Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.
    J Virol. Sep 05 [Epub ahead of print].

Immunofluorescence

Immunohistology - Frozen

Synonyms

RSV

RRID

AB_620536